Research to be presented highlights the strong therapeutic potential of integrin agonists in treatment of lupus nephritis, focal segmental glomerulosclerosis, and other rare kidney disorders Allosite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback